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ABSTRACT 
 
 
 
 
CHARACTERIZATION OF PUTATIVE ACETATE KINASE IN THE PATHOGENIC 
YEAST, CRYPTOCOCCUS NEOFORMANS 
 
Beth Budden, M.S. 
Western Carolina University (April 2013) 
Director:  Dr. Indrani Bose 
 
 The spherical, encapsulated basidiomycetous yeast, Cryptococcus neoformans, is 
an environmental opportunistic pathogen that has become a leading cause of mortality 
secondary to HIV/AIDS, particularly in sub-Saharan Africa (Park et al. 2009).   Few 
chemotherapeutic agents are currently available to treat cryptococcosis, and growing 
concerns over resistance to some of these medications have emphasized the need for 
alternative treatments.  By obtaining a thorough understanding of the metabolic pathways 
involved in the survival and pathogenicity of this organism it is hoped that pathways 
and/or proteins unique to the organism can be used as potential targets for 
chemotherapeutic agents (Casadevall and Perfect 1998).  A homolog of an enzyme 
previously thought to exist only in bacteria, acetate kinase (AK), has been identified in 
certain lower eukaryotes including C. neoformans.  To date, an acetate kinase homolog 
has not been found in higher eukaryotic organisms.  
 
	  
 To get a better understanding of the role acetate kinase plays in C. neoformans, 
pre-constructed ACK1 deletion strains (ack1Δ) were confirmed via cDNA analysis and 
Southern blot and were used in a variety of phenotype characterization studies.  No 
phenotypic difference between the wild type and ack1Δ strains were observed.  A 
plasmid designed for use in complementation studies was constructed but not utilized due 
to the absence of phenotypic variation.  Several strains containing mCherry-tagged ACK1 
were created and initial PCRs of the 5’ and 3’ ends suggest proper placement of the 
ACK1-mCherry cassette within the C. neoformans genome.  Following additional 
placement confirmation studies, these strains can be used to identify subcellular 
localization of this protein and allow purification of the endogenous protein from cell 
lysate that can be used for enzyme kinetic studies as well as for identifying possible 
interacting proteins.  Further exploration is needed to elucidate acetate kinase’s role in 
this microorganism.    
 
 
   
 
 
 
 
 
1. Casadevall, A, Perfect, JR.  (1998). Cryptococcus neoformans. Washington, DC. 
American Society for Microbiology. 
 
2. Park, BJ, Wannemuehler, KA, Marston, BJ, Govender, N, Pappas, PG, Chiller, 
TM.  (2009).  Estimation of the Current Global Burden of Cryptococcal 
Meningitis Among Persons Living With HIV/AIDS. AIDS.  23(4): 525-530.
9	  	  
INTRODUCTION 
 
 
 
Cryptococcus neoformans 
Cryptococcus neoformans is a small haploid, single-celled, spherical yeast 
belonging in the phylum Basidiomycota.  This fungus is most commonly encountered as 
budding yeast, its vegetative state (Hull and Heitman 2002), however under certain 
nutrient deprivation, these cells can sexually reproduce if both mating types, mat a and 
mat α, are present (Hull and Heitman 2002).  This union results in the formation of 
filaments at the end of which basidia, containing basidiospores are produced.  Under 
adequate conditions, the basidiospores can grow into vegetative yeast cells (Hull and 
Heitman 2002).  Environmental and clinical strains of C. neoformans have shown to be of 
predominantly the α mating type arguing against sexual reproduction being a common 
practice.  In 1996, Wickes et al. described similar filamentation resulting in the formation 
of basidiospores occurring in mat α strains in the absence of the mat a mating type 
(Wickes et al. 1996).  This phenomenon, haploid or monokaryotic fruiting, has now 
become the most reasonable explanation for the presence of basidiospores in an organism 
found predominantly as one mating type (Hull and Heitman 2002).  
 C. neoformans is an environmental microorganism that is found globally in soil 
and has been commonly associated with pigeon feces and other bird excreta (Casadevall 
and Perfect 1998).    The presence of yeast cells and basidiospores in the environment 
does not usually present a problem for most people with healthy immune systems.  While 
it is considered an opportunistic pathogen, cases of cryptococcosis in patients with no 
known immune deficiencies have been documented in China (Chen et al. 2008), and 
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infections involving immunocompetent individuals by a related species (C. gattii) were 
reported in the Pacific Northwest (Datta 2009).   
Cryptococcosis 
 The first documented clinical case of cryptococcosis occurred in 1894 in 
Germany and the first environmental isolate of C. neoformans was discovered in Italy 
that same year.  It is believed that elevated awareness about the pathogen has led to more 
numerous and definitive diagnoses of the disease.  Following the explosion of the AIDS 
epidemic in the early 1980s, the number of cryptococcosis cases rose abruptly 
(Casadevall and Perfect 1998).  A study published in 2009 by Park et al. estimated the 
number of cryptococcal meningoencephalitis cases annually to be approximately 957,900 
with about 624,700 resulting in death.  Most of these cases occurred in underdeveloped 
nations, especially sub-Saharan Africa where access to antiretroviral agents for 
AIDS/HIV patients is minimal (Park et al. 2009).   
 C. neoformans most commonly enters its host through the respiratory system 
resulting in lung masses, however it can manifest itself as a primary skin lesion caused by 
introduction through broken skin, skin lesions secondary to internal infection, and can 
cross the blood-brain barrier leading to meningoencephalitis (Neuville 2003).  It is not 
known whether aerosolized desiccated yeast cells or basidiospores that are produced by 
the organism are to blame for infection however due to their size and their ability to 
withstand desiccation and nutrient deprivation, basidiospores are most commonly thought 
to be the infecting agent (Wickes et al. 1996).  By comparing clinical and geographical 
isolates of C. neoformans, it was demonstrated that the organism can remain dormant 
within its host for an extended period of time.  If the host’s immune system weakens, the 
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yeast can begin multiplying resulting in disease (Garcia-Hermoso et al. 1999).  The 
amount of time that C. neoformans can remain dormant, however, remains unknown.  
 The pathogenicity of C. neoformans can be attributed to the characteristics that 
contribute to its virulence including its ability to synthesize a polysaccharide capsule, to 
produce melanin, to tolerate environmental stressors such as warm temperatures, and 
oxidative and nitrosative stressors.  The most notable virulence is its ability to produce a 
polysaccharide capsule.  The capsule provides protection for the cell from desiccation, 
masks proteins located on the cell wall that could signal the host’s immune system to the 
presence of the pathogen, and it can make phagocytosis mechanically challenging 
(McQuiston and Del Poeta 2011, Zaragoza et al. 2009).  The cell’s ability to produce 
melanin is another important virulence factor.  In addition to helping protect the cell from 
harmful environmental conditions such as exposure to UV light, components of melanin 
are believed to help aid in the organism’s ability to withstand oxidative and nitrosative 
stress that is encountered upon engulfment by the phagocytic cells of the immune system 
(Wang and Casadevall 1994).  The cell’s ability to withstand the relatively warm internal 
human body temperature of 37˚C is also considered a virulence factor.   
Treatments for Cryptococcosis 
 At this time, there are limited chemotherapeutic agents that are effective against 
this environmental opportunistic pathogen.  Combinations of amphotericin B, 
fluconazole, and 5-flucytosine are the most commonly used drugs used to treat 
cryptococcosis; however, certain combinations of these drugs can result in kidney 
toxicities and drug resistance to 5-flucytosine when used as a sole therapeutic agent has 
been reported (Saag et al. 2000).  Additionally, while only a few clinical strains in Africa 
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have demonstrated resistance to fluconazole, long-term antifungal drug regimens, 
commonly used to combat cryptococcosis as well as other opportunistic fungal infections 
have raised concerns over antifungal drug resistance and have prompted monitoring of 
such (Govender et al. 2011).  Newer drugs and alternative therapies including the use of 
monoclonal antibodies have demonstrated favorable laboratory results but little clinical 
data is available (Pappas 2011).   
 It has been suggested that targeting metabolic pathways that affect survival or 
virulence of a pathogen might be a more effective way to eradicate the pathogen 
(Casadevall and Perfect 1998).  One such pathway is the calcineurin signaling pathway.  
The calcineurin pathway plays many roles in C. neoformans including inducing responses 
to changes in the environment that affect its virulence such as heat tolerance and cell wall 
synthesis, and it is believed to be responsible for drug tolerance to a class of antifungal 
medications used for C. albicans (Fox et al. 2011).  Cyclosporin A, a drug that inhibits 
signaling of this pathway has demonstrated growth inhibition in C. neoformans and C. 
gattii (Mody et al. 1988 and Chen et al. 2013).  While the identification of enzymes 
and/or pathways utilized by pathogens provide potential targets for drug therapy, 
enzymes or pathways utilized by pathogens but not their hosts have the potential benefit 
of treating the disease while minimally affecting the host.     
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Acetate Kinase 
 The rapidly increasing number of sequenced genomes and search tools such as 
BLAST (Basic Local Alignment Search Tool) have enabled the identification of 
homologous proteins utilized by other organisms so that we can use what has been 
learned from well-studied organisms, such as E. coli, to try to better understand their role 
in other organisms.  In 2006, Ingram-Smith et al. described the discovery of a putative 
homologous protein acetate kinase (AK), an enzyme whose role in bacteria and in the 
Methanosarcina genus of Archaea has been well studied, in C. neoformans (Ingram-
Smith et al. 2006).  In addition to sequence similarities identified in a BLAST query, 
amino acids that make up the phosphoryl donor/acceptor (ATP/ADP) binding sites as 
well as residues that make up the acetate binding pocket of AK in M. thermophila are 
conserved in C. neoformans (Ingram-Smith et al. 2006; Thaker et al. 2013).  Putative 
homologs of AK have been identified in other lower eukaryotic organisms, some of 
which are pathogenic including Entamoeba histolytica and Aspergillus fumigatus (Bragg 
and Reeves 1962; Ingram-Smith et al. 2006).  Interestingly, no homologs have, as yet, 
been found in humans or other higher eukaryotes suggesting the presence of a unique 
pathway that could be targeted by chemotherapeutic agents (Ingram-Smith et al. 2006).  
 In bacteria, acetate kinase is an enzyme that is part of the glyoxylate pathway that 
is responsible for the assimilation of acetate from excess acetyl-CoA, an important 
metabolic intermediate (Ingram-Smith et al. 2006).  During aerobic respiration and under 
high glucose concentrations, the production of acetyl-CoA exceeds the amount that the 
cell can utilize for important metabolic processes such as the energy generating 
tricarboxylic acid cycle and fatty acid biosynthesis (Wolfe 2005).  As a result, excess 
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acetyl-CoA is converted into acetate through a reversible acetate assimilation pathway in 
which excess Acetyl-CoA is converted into acetyl-phosphate by the enzyme 
phosphotransacetylase (PTA).  An inorganic phosphate is transferred from acetyl 
phosphate to ADP to produce the high-energy molecule ATP and acetate (Wolfe 2005).  
The acetate produced is then excreted the acetate from the cell.  When carbon stores 
become depleted, the acetate is actively transported into the cell and converted back into 
acetyl-CoA by the enzyme acetyl-CoA synthetase (ACS) (Wolfe 2005).   
 In C. neoformans, however, specifics of the glyoxylate pathway have not yet been 
elucidated.  According to Ingram-Smith et al. (2006), one striking difference between the 
pathway in E. coli and that in C. neoformans is the absence of a phosphotransacetylase 
(PTA) homolog, the enzyme responsible for producing the substrate, acetyl-phosphate, in 
C. neoformans. This absence led Drs. Kerry Smith and Cheryl Ingram-Smith, our 
collaborators at Clemson University, to suggest that this PTA pathway is not used to 
synthesize the acetate precursor.  Instead, the Smith lab has identified two homologs 
(XFP1p and XFP2p) of an enzyme previously thought to be present only in bacteria, 
xylulose 5-phosphate/fructose 6-phosphate phosphoketolase, XFP.  In bacteria, XFP 
catalyzes a reaction that breaks down D-xylulose 5-phosphate or D-fructose 6-phosphate 
to produce acetyl-phosphate (Meile et al. 2001).  Interestingly, the gene that codes for 
this enzyme has been closely linked to genes that code for PTA and/or AK in several 
bacteria (Meile et al. 2001). 
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Reverse Genetics 
 One manner in which information about the function of specific proteins and their 
role(s) in various organisms can be gained is through reverse genetics studies.  This 
approach involves identification of putative homologous proteins using programs such as 
BLAST (Basic Local Alignment Search Tool).  These programs search genome sequence 
databases for nucleotide or amino acid sequence similarities to a gene or protein of 
interest.  Once one is identified, the DNA sequence data can be used to produce mutant 
strains in which the protein of interest is rendered nonfunctional by introducing mutations 
within gene, deleting the gene from the genome, or by performing RNA interference 
(RNAi) in which small gene sequences are used to induce destruction of mRNA 
containing the same sequence.  Once the gene is disrupted, the mutant organism is 
subjected to different environmental conditions and its phenotypic response observed and 
compared to that of the normal, wild type (WT) organism.  If a difference in phenotype is 
revealed, complementation is performed to induce normal gene function in an attempt to 
restore the WT phenotype.  Information gained by identifying conditions that elicit a 
different phenotype increase the understanding about its role in the organism.   
Creation of ack1Δ  strains 
 To learn more about the role AK plays in C. neoformans, this reverse genetics 
study was initiated.  Dr. Indrani Bose created fourteen strains in which the gene encoding 
acetate kinase, ACK1, was deleted.  The construct that was used to create the mutant 
strains contained three parts:  the 5’ untranslated region upstream of ACK1, a neomycin 
resistance gene (NEOR), and the 3’ untranslated region.  This construct that was used to 
was produced using overlap PCR of the three fragments listed above as the template.  
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Once the entire construct was confirmed, it was PCR amplified, coated onto gold beads 
and shot into KN99 C. neoformans cells (WT) using a gene gun.  Cells that underwent 
homologous recombination and successfully integrated the construct into their genome, 
replacing ACK1 with NEOR, were able to grow in the presence of neomycin.  Genomic 
DNA extractions were performed on the colonies that arose on the neomycin plates and 
used as the template for PCRs to test for the presence of the construct within the genome.  
Fourteen strains demonstrated amplification of a portion of NEOR.   
 In order to ensure the complete and clean deletion of ACK1, further confirmation 
studies were performed.  A cDNA analysis was used to ensure that mRNA coding for AK 
was not being produced in the ack1Δ stains, and a Southern blot using probes for ACK1 
and NEOR was performed to demonstrate that a single integration of NEOR had occurred 
and that ACK1 had been removed from the genome.  It is important to demonstrate that 
proper placement of the NEOR to ensure that it had not integrated randomly resulting in 
the disruption of another gene.  These microbes were then used in a number of 
experiments to observe the phenotypes the cells exhibit under a variety of conditions to 
try to reveal a difference in phenotype between the ack1Δ strains and the WT strain 
(KN99) that will offer a clue as to the role AK plays in C. neoformans.  It was thought 
that a starting place would be to test the ack1Δ strain’s carbon source utilization abilities 
since AK is utilized in E. coli to deal with excess acetyl-CoA in high glucose condition.  
The other phenotypes tested in this study involve virulence factor characteristics of the 
pathogen including polysaccharide capsule synthesis, melanization, temperature 
tolerance, tolerance to hypoxic, nitrosative, and oxidative stressors among others because 
a defect in any of these abilities could possibly attenuate the pathogen.  A plasmid 
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containing ACK1 was constructed for complementation studies in the event a unique 
phenotype was observed.  Finally, five C. neoformans strains were created in which 
ACK1 is tagged with the red fluorescent protein, mCherry, which can be used for 
subcellular localization of acetate kinase within the cell.  It can also be used to purify AK 
from cell lysate using antibodies against mCherry.  The purified protein can then be used 
for enzyme activity assays.   
Significance 
 The motivation behind this reverse genetics study is to characterize the phenotype 
of Cryptococcus neoformans mutants lacking the acetate kinase gene (ACK1) in hopes 
that it will broaden our understanding of how the expression of ACK1 affects cell 
function.   It is hopeful that this information will help elucidate the metabolic pathway of 
which AK is believed to play a role.  By gaining a thorough understanding of important 
metabolic pathways including intermediate substrates and enzymes, especially ones that 
are unique to pathogenic organisms, potential targets for chemotherapeutic agents may be 
identified.  To date, the gene that encodes this enzyme has not been characterized in C. 
neoformans.  It is this gap in the literature was the driving force behind this reverse 
genetics study.  
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MATERIALS AND METHODS 
 
 
 
cDNA Analysis for ack1Δ  Strain Confirmation 
 Total RNA was extracted from 3 ml overnight cultures grown in YPD (1% (w/v) 
yeast extract, 2% (w/v) peptone, and 2% (w/v) dextrose) at 30˚C using the Trizol method.  
The cells were centrifuged using an Eppendorf 5801R centrifuge rotor FA-45-30-11 at 
956 x g for 5 minutes at 4˚C.  The cells were bead beaten at room temperature (RT) in 
750µl of TRIzol® 8 times (1 min beating followed by 2 min incubation on ice).  The 
lysate was incubated for 10 minutes at room temperature (RT), treated with 1/5th 
chloroform, incubated at RT for 5 min, and centrifuged at 15,294 x g for 15 minutes at 
4˚C.  An equal volume of isopropanol was added to the supernatant, incubated at 10 min 
at RT, and centrifuged at 15,294 x g for 10 min at 4˚C.  The pellets were washed in 70% 
ethanol, air dried, and resuspended in 40 µl of diethylpyrocarbonate (DEPC)-treated 
water.  RNA was precipitated using 7.5 M LiCl to a final concentration of 2.5 M and 
incubating overnight at -20˚C.  The RNA was pelleted by centrifugation at 20,817 x g for 
20 min at 4˚C.  The pellets were washed twice in 70% ethanol, air dried, resuspended in 
50 µl of DEPC water, and quantitated on a Nanodrop 1000.  0.5 µg of total RNA was 
used in a 20 µl reaction to synthesize cDNA using the Thermo Scientific Verso™ cDNA 
Synthesis Kit (Cat no:  AB-1453/A and Lot no:  0612/17).  
 Amplification of ACK1 cDNA (using primers KIO25 and KIO26) and ACT1 
cDNA (using primers BLO01 and BLO02) in the same reaction was performed (see 
Appendix A for a list of primers).  Each reaction was performed in a final volume of 
about 50 µl using 3 µl cDNA template from the above procedure with 10x PCR buffer 
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and Taq polymerase.  A cycle consisting of 94˚C for 30 sec, 30 cycles of 94˚C for 30 sec 
followed by annealing at 60˚C for 30 sec and extension at 72˚C for 1.5 min, and a final 
extension of 5 min was used for this amplification.  A 0.8% (w/v) TBE-agarose gel was 
used for visualization. 
 All DNA agarose gels were made with TAE buffer (Tris-acetate-EDTA) or TBE 
buffer (Tris-borate-EDTA) containing 0.05 µl/ml of ethidium bromide for visualization.  
The gels were 0.8% (w/v) in concentration unless noted otherwise. 
Southern Blot Analysis for ack1Δ  Strain Confirmation 
 Amplification of ACK1 probe (using primers KIO21 and KIO22) was performed 
in a 50 µl reaction on a cycle consisting of 98˚C for 30 sec, 30 cycles of 98˚C for 10 sec, 
annealing at 54˚ for 15 sec and a 17 sec extension at 72˚C, and a final 5 min extension at 
72˚C.   Amplification of the NEOR probe (using primers KIO23 and KIO24) was 
performed in 50 µl reactions on a cycle consisting of 98˚C for 30 sec, 30 cycles of 98˚C 
for 10 sec, annealing at 59˚ for 15 sec and a 26 sec extension at 72˚C, and a final 5 min 
extension at 72˚C.   5 µl of each probe were visualized using a 0.8% TBE-agarose gel.  
The probe DNA was purified using the Promega Wizard® SV Gel and PCR Clean-Up 
System and eluted in 50 µl of the provided nuclease-free water.  5 µl of each sample was 
run on a 0.8% TAE-agarose gel for visualization and 0.2 µl was quantified on a 
Nanodrop 1000.  100 ng of probe DNA was used to prepare the probe using Amersham 
Gene Images™ AlkPhos Direct™ Labeling and Detection kit.   
 Two sets of XhoI (NEB) and SpeI (NEB) restriction digests were performed, each 
containing 10 µl of gDNA using 10x BSA (NEB) and Buffer 4 (NEB) in 35 µl reactions.  
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The digests were incubated 27 hours at 37˚C.  Fifteen µl of each sample was run on a 
0.8% TAE-agarose gel and visualized.   
 The gel was soaked depurination buffer (11 ml HCl in 989 ml DI H2O) for 10 min 
with gentle agitation, rinsed in DI water, soaked in denaturation buffer (87.66 g NaCl and 
20 g NaOH in 1L) for 30 min with gentle agitation, rinsed, and soaked in neutralization 
buffer (87.66 g NaCl and 60.5 g Tris base in 1L with pH adjusted to 7.5), 30 minutes with 
gentle agitation, and rinsed. 
 The DNA was transferred onto the Amersham Hybond™-N+ nylon transfer 
membrane with 1X nucleic acid transfer buffer (4.41 g Tri-sodium citrate and 8.77 g 
NaCl in 1 L pH adjusted to 7.8).  The membrane was dried for 2 hrs at 80˚C.  
 100 ng of ACK1 and NEOR probe were used in separate probe hybridization 
reactions each containing 10 ml of pre-warmed hybridization buffer (0.5 M NaCl and 4% 
(w/v) blocking reagent added to kit-supplied hybridization buffer).  The tubes were 
allowed to incubate overnight at 55˚C. 
   Following overnight hybridization, each blot was washed twice in preheated 
primary wash solution (120 g urea, 1 g SDS, 100 ml of 0.5 M sodium phosphate pH 7.0, 
8.7 g NaCl, 1 ml of 1.0 M MgCl2, and 2 g blocking reagent (supplied in kit) in 1 L) for 10 
min at 55˚C with gentle agitation and washed twice in 125 ml of 1x secondary wash 
solution (12.5 ml of a 20X secondary wash solution (121 g Tris base and 112 g NaCl in 
1L) and 237.5 ml of DI water, and 500 µl of 1M MgCl2) for 5 min at RT.  The excess 
wash buffer was drained from the blot, 2 ml of CDP Star was applied to each blot, and 
incubated for 5 min at RT.  The blots were wrapped and exposed to autoradiography film 
for approx 1 hr and the film was manually developed.   
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Phenotype Characterization Studies 
Carbon Source Utilization: 
 Petri plates containing media for testing the utilization of carbon sources were 
prepared (6.8 g/L Difco yeast nitrogen base (YNB) without amino acids and 18 g/L of 
agar).  Glucose, galactose, sucrose, sorbitol, ethanol, glycerol, and D-xylose were added 
to separate batches of medium in 2% and 0.2% concentrations, and sodium acetate was 
added to the medium in 0.25%, 0.5%, and 2% concentrations.  The plates were inoculated 
with KN99 mat α and a variety of ack1Δ strains and incubated at 30˚C for at least three 
days.   
Temperature Sensitivity: 
 YPD plates (YPD (50 g/L), and agar (18g/L) were streaked with KN99 mat α and 
a variety of ack1Δ strains.  The plates were incubated at room temperature (RT), 30˚C, 37 
˚C, and 40˚C for at least 3 days. 
Melanin Production: 
 Niger seed agar plates (niger seed (70 g/L), glucose (2%), and agar (20 g/L) 
(Griffith 2012) were inoculated with KN99 mat α and a variety of ack1Δ strains in a 
circular manner.  The plates were placed in the dark and incubated at RT until melanin 
was observed (Griffith 2012).   
Nitrosative Stress:  
 Nitrosative stress plates (YNB without amino acids (6.8 g/L), agar (18 g/L), and 
0.1 M NaNO2 (7.5 ml/L)) were streaked KN99 mat α and a variety of ack1Δ strains and 
incubated at 30˚C for at least three days.   
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Hypoxia-Mimicking Conditions Using CoCl2: 
 The 0.7 mM, 0.53 mM, and 0.25 mM CoCl2 plates (YNB without amino acids 
(6.8 g/L) and agar (18 g/L), and 0.1M CoCl2) were inoculated with KN99 mat α and a 
variety of ack1Δ strains were streaked onto the plate, and the plate was incubated at 30˚C 
for at least three days (Ingavale et al. 2008).  
pH: 
 The pH plates (YPD (50 g/L), agar (18 g/L) adjusted to pH 5, pH 7, pH 9, and pH 
11 using NaOH or HCl) were streaked with KN99 mat α and a variety of ack1Δ strains 
and incubated at 30˚C for at least three days. 
Filamentation Following Sexual Reproduction: 
 Each of the ack1Δ strains were mixed with KN99 mat a  and KN99 mata α 
separately on YPD (50 g/L) and incubated overnight at 30˚C.  Mating plates (1X 
Murashige-Skoog Basal Salt Mixture and agar (17 g/L) to pH 5.7) were streaked with 
each sample and allowed to incubate in the dark at RT until filamentation was observed.  
The filamentation was photographed using a Leica MZ125 microscope in Dr. Pechmann’s 
lab.   
Oxidative Stress Using H2O2: 
 The 0.75 mM, 0.5 mM, and 0.25 mM oxidative stress plates (YNB without amino 
acids (6.8 g/L), agar (18 g/L), pH 7, and 0.1M H2O2) were streaked with KN99 mat α and 
a variety of ack1Δ strains and incubated at 30˚C for at least three days. 
23	  	  
Cluster Growth Phenotype: 
 YPD broth (5 ml) and minimal medium broth (5 ml) were inoculated with KN99 
mat α and a variety of ack1Δ strains and incubated overnight at 30˚C.  Nikon Microphot-
FXA microscope was used for documentation.  
Capsule Formation: 
 KN99 mat α and a variety of ack1Δ strains were incubated at 30˚C in 10 ml 
Sabouraud medium (1% (w/v) peptone, 4%  (w/v) dextrose in DI H2O) for approximately 
20 hours with moderate shaking.  One ml of each sample was centrifuged at 14,000 x g 
for 5 minutes, washed twice in 500 µl of 1X PBS (NaCl (137 mM), KCl (2.7), KH2PO4 
(1.5 mM), and Na2HPO4 (8.5 mM)), and centrifuged at 14,000 x g for 5 minutes.  The 
cells were resuspended in 200 µl of capsule-inducing medium (1/10 Sabouraud in 50 mM 
pH 7.3 MOPS) and transferred to 10 ml of capsule-inducing medium.  The cells were 
incubated for approx. 18 hours at 37˚C with moderate shaking (Zaragoza and Casadevall 
2004).  The cells were observed and photographed using a microscope at Clemson 
University and a Nikon Microphot-FXA microscope.   
Cell Wall Integrity: 
 Cell wall integrity plates (YPD (50 g/L), agar (18 g/L), and Congo Red stain (5 
ml/L) or 10% SDS (1 ml/L) were streaked with KN99 mat α and a variety of ack1Δ 
strains and incubated at 30˚C for at least three days.   
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ACK1 Complementation Plasmid for Electroporation 
 Genomic DNA was extracted from 3 ml of overnight cultures grown in YPD (50 
g/L) at 30˚C.  The cells were centrifuged using a table top centrifuge at 14,000 x g, 
resuspended in 500 µl of extraction buffer (50 mM TRis-HCl (pH 8.0), 20 mM EDTA, 
and 1% SDS), bead beaten using a vortexer at 5 min intervals followed by 1 min ice 
incubation until 50-80% of cells lysed, and incubated at 70˚C for 10 min.  Five molar 
potassium acetate (200 µl) and 5 M NaCl (150 µl) were added to each tube, mixed, 
incubated on ice for 20 minutes, and centrifuged at 14,00 x g at RT for 10 minutes and 
the supernatant was transferred to new tubes.  Chloroform (450 µl) was added to the 
supernatant, mixed, and centrifuged at 14,000 x g at RT for 10 minutes.  The aqueous 
phase (top phase) was transferred to new tubes.  Twenty µl of 30% PEG8000 was added 
to the aqueous phase and centrifuged at 14,000 x g for 10 minutes.  The pellet was 
resuspended in 50 µl of H2O, 1 µl of RNase (500 µg/ml) added, and incubated in a 37˚C 
water bath for 30 minutes.  A tenth of a volume of 3 M sodium acetate (5 µl) and 3 
volumes of 100% ethanol (150 µl) were added, incubated at -20˚C at least 30 min, and 
centrifuged at 4˚C on 14,000 x g for 10 minutes.  The pellet was resuspended in 50 µl of 
H2O (Bose 2009). 
 A 50 µl PCR (BLO11 and BLO12) using 5X Phusion® HF Reaction Buffer, 
Phusion® Taq Polymerase, and 1.0 µl of template DNA (KN99 mat α) was run on a 
cycle consisting of 30 sec at 98˚C, 30 cycles of 98˚C, annealing at 61˚C for 15 sec, and a 
2 min extension at 72˚C, and a final 5 min extension at 72˚C.  The PCR products were 
purified using Qiagen® QIAquick® PCR Purification Kit.  Five µl was visualized on a 
0.8% TBE-agarose gel.   
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 A miniprep of pHYG7-KB1 vector using 3 ml of overnights grown in LB + 
ampicillin (100 mg/ml) was performed using Qiagen® QIAprep® Spin Miniprep Kit.  The 
DNA was eluted in H2O (50 µl) and stored at -20˚C.    
 SpeI (NEB) digest of the purified ACK1 PCR (15 µl) and pHYG7-KB1 (15 µl) 
were digested using Buffer 4 (NEB), 10x BSA (NEB) in 60 µl reactions.  The tubes were 
incubated overnight at 37˚C.  SpeI was inactivated via incubation at 80˚C for 20 min. 
 1 µl of NEB CIP (calf intestinal alkaline phophatase) was added to the SpeI-
digested pHYG7-KB1 vector and incubated at 37˚C for 1 hr. 
 An ethanol precipitation was performed using one-tenth volume (6 µl) of 3 M 
sodium acetate and 3 volumes (180 µl) of 100% ethanol to each digest.  They were 
incubated overnight, and centrifuged at 4˚C for 30 minutes.  Seventy percent ethanol (200 
µl) was added and the pellets, centrifuged at 4˚C for 15 min, and air-dried.  The DNA 
was resuspended in 40 µl of H2O.  One half µl of each was visualized on a 0.8% TBE-
agarose gel with ethidium bromide for visualization. 
 ACK1 (6 µl) was ligated into pHYG7-KB1 (2 µl) in a 20 µl reaction containing 
T4 DNA ligase buffer and T4 DNA ligase.  The reaction was incubated at 16˚C for 36 
hours.   
 Competent E. coli cells were chemically transformed using 8 µl of linearized 
vector in one transformation and 8 µl of ligation reaction in a second transformation.  The 
tubes were incubated on ice for 30 min and incubated at 37˚C for 45 seconds.  SOC (250 
µl) was added, the tubes incubated for 1 hour at 37˚C, plated on LB + ampicillin (100 
mg/ml), and incubated overnight at 37˚C.     
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 Colony PCRs were performed (using primers KIO21 and KIO22) using 10x PCR 
Buffer and Taq polymerase in 20 µl reactions.  The reactions were run on a cycle of 30 
sec at 94˚C, 30 cycles of 30 sec at 94 ˚C, annealing at 57˚C for 30 sec and 45-sec 
extension at 72˚C, and a final 5-min extension at 72˚C.  Five µl of was run on a 0.8% 
TBE-agarose gel for visualization. 
 Minipreps using 3 ml of overnight cultures of colonies #2 and #7 grown in LB + 
amp (100 mg/ml) at 37˚C were performed using the Qiagen® QIAprep® Spin Miniprep 
Kit. 
 Three 15 µl XbaI digests of colonies #2 and #7 and pHYG7-KB1 vector using 
Buffer 4 (NEB), 10x BSA (NEB), and 3 µl of miniprep DNA and vector only were 
incubated overnight at 37˚C.  The entire reaction was run on a TBE-0.8% agarose gel for 
visualization.  
ACK1-mCherry Construct for Subcellular Localization of Acetate Kinase 
 The three fragments making up the ACK1-mCherry construct were PCR 
amplified. 
 A 50 µl PCR of fragment #1 (using primers KIO27 and KIO28) using 5x HF 
Buffer, Phusion Taq polymerase, and KN99 mat α as template was run on a cycle of 30 
sec at 98˚C, 30 cycles of 10 sec at 98˚C, 15 sec annealing at 63˚C, and 1 min-45 sec 
extension at 72˚C, and a final 6-min extension at 72˚C.   
 A 50 µl PCR of fragment #2 (using primers KIO29 and KIO30) using 5x HF 
Buffer, Phusion Taq polymerase, and pLKB25 (containing mCherry-NEOR) as template 
was run on a cycle of 30 sec at 98˚C, 30 cycles of 10 sec at 98˚C, 15 sec annealing at 
65˚C, and 1 min-45 sec extension at 72˚C, and a final 6-min extension at 72˚C.  
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 A 50 µl PCR of fragment #3 (using primers KIO31 and KIO32) using 5x HF 
Buffer, Phusion Taq polymerase, and KN99 mat α as template was run on a cycle of 30 
sec at 98˚C, 30 cycles of 10 sec at 98˚C, 15 sec annealing at 60˚C, and 1 min extension at 
72˚C, and a final 5-min extension at 72˚C.   
 Fragments #1 and #3 were PCR purified using the Qiagen® QIAquick® PCR 
Purification Kit.  Fragment #2 was cut from the gel and purified using the Qiagen® 
QIAquick® Gel Purification Kit.  The fragments were eluted in 50 µl of H2O.  Five µl of 
each was run on a 0.8% TBE-agarose gel for visualization.  
 Fragment #1 digested with SpeI in a 60 µl reaction containing Buffer 4 (NEB), 
10x BSA (NEB) and 12 µl of fragment #1 for 4 hrs at 37˚C, incubated at 80˚C for 20 
minutes, then digested with BamHI (NEB) at 37˚C for 4 hrs.  The digest was purified 
using the QIAquick® PCR Purification Kit and eluted in 50 µl of H2O. 
 Fragment #2 was digested with SpeI and NdeI in a 60 ml reaction containing 
Buffer 4 (NEB), 10x BSA (NEB) and 20 µl of fragment #2, incubated 37˚C for 4 hrs then 
purified using the QIAquick® PCR Purification Kit.  The DNA was eluted in 35 µl of 
H2O. 
 Fragment #3 was digested with NdeI (NEB) in a 60 µl reaction using Buffer 4 
(NEB), 10x BSA (NEB), and 12 µl of fragment #3, incubated at 37˚C for 4 hrs.  The 
digest was PCR purified using the QIAquick® PCR Purification Kit, and the DNA was 
eluted in 30 µl of H2O.  A second 60 µl KpnI digest was performed using Buffer 1 
(NEB), 10x BSA (NEB), and all of the purified NdeI-digested fragment #3, incubated at 
37˚C for 4 hrs, purified using the QIAquick® PCR Purification Kit, and eluted in 50 µl of 
H2O.  
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 The vector, pCR2.1 Topo, was digested with BamHI using Buffer 4 (NEB), 10x 
BSA (NEB), and 12 µl of the vector, incubated at 37˚C for 4 hrs, PCR purified using the 
QIAquick® PCR Purification Kit, eluted in 30 µl of H2O.  A second digest was 
performed in a 60 µl reaction using Buffer 1 (BSA), 10x BSA (NEB), and 30 µl of 
purified BamHI-digested vector, incubated at 37˚C 4 hours, PCR purified using the 
QIAquick® PCR Purification Kit, and eluted inn 50 µl of H2O. 
 Five µl of each of the three fragments and the vector were separated on a 0.8% 
TBE-agarose gel for visualization and relative concentration determination.   
 Two ligation reactions of the ACK1-mCherry construct were performed, one 
using T4 DNA ligase buffer, 1 µl of vector, 1 µl of fragment #1, 3 µl of fragment #2, 0.5 
µl of fragment #3, and T4 DNA ligase,  and the other reaction using T4 DNA ligase 
buffer, 1 µl of vector, 2 µl fragment #1, 6 µl of fragment #2, 1 µl of fragment #3, and T4 
DNA ligase.  The reactions were incubated overnight at 16˚C. 
 Transformation of the 4 µl of each ligation reaction into competent E. coli cells 
was performed as described above and colony PCRs on the transformants were done 
using the primers KIO21 and KIO22, 10x PCR Buffer, and Taq polymerase.  The PCRs 
were run on a cycle consisting of a 30 sec at 94˚C, 30 cycles of 30 sec at 94˚C, a 30 sec 
annealing step at 59˚C and a 45 sec extension step at 72˚C, and a final 5 min extension 
step at 72˚C.  Five µl of each reaction was run on a 0.8% TBE-agarose gel for 
visualization. 
 Minipreps were performed using the Qiagen® QIAprep® Spin Miniprep Kit on 
colonies A8, B6, B7, B10, and B11.  XhoI restriction digests (15 µl) were performed 
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using Buffer 4 (NEB), 10x BSA (NEB), and 3 µl of plasmid DNA, incubated overnight at 
37˚C, and run on a 0.8% TBE-agarose gel for visualization.  
 Four 50 µl PCRs in which only the annealing temp was varied were performed in 
preparation for biolistic transformation using primers KIO27 and KIO32, 5X HF Buffer, 
Phusion Taq polymerase, and 1 µl of the colony A8 miniprep DNA.  The reaction was 
run on a program consisting of 10 sec at 98˚C, 30 cycles of 10 sec at 98˚C, 10 sec 
annealing steps at 62˚C, 63˚C, 63.5˚C, and 64˚C, and a 3 min extension step at 72˚C, and 
a final 5 min extension step at 72 ˚C.  The PCR products were purified using the 
QIAquick® PCR Purification Kit and eluted in 30 µl of H2O.  One µl of each sample was 
run on a 0.8% TBE-agarose gel for visualization.     
 Six biolistic transformations of KN99 mat α cells with the ACK1-mCherry 
constructs were performed by Dr. Bose at Washington University in St. Louis, Missouri.  
The six transformation reactions were plated on YPD + G418 plates and mailed back to 
WCU to confirm the presence and placement of the entire ACK1-mCherry construct. 
 Genomic DNA extractions, as described above, were performed on the 
transformants and confirmation 20 µl PCRs of the 5’ and 3’ ends of the construct were 
performed.  The PCRs consisted of 5X HF Buffer, primers KIO33 and BLO45 for the 5’ 
end confirmation and primers BLO46 and KIO12 for the 3’ end confirmation, Phusion 
Taq polymerase, and 3.0 µl of gDNA.  The 5’ end PCRs were run on a program 
consisting of 30 cycles that included a 10-second denaturation step at 98˚C, a 30-second 
annealing step at 56˚C, and a 1-minute, 40-second extension step at 72˚C, and the 3’ end 
PCRs were run on a program that consisted of 30 cycles that included a 10-second 
denaturation step at 98˚C, a 30-second annealing step at 63˚C, and a 1-minute, 15-second 
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extension step at 72˚C.    Both programs included an initial 10-second denaturation step 
at 98˚C and a final 5-minute extension step at 72˚C.  Five µl of each reaction were run on 
a 0.8% TAE-agarose gel for visualization.   
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RESULTS AND DISCUSSION 
 
 
 
cDNA Analysis for ack1Δ  Strain Verification 
 cDNA analysis was performed to confirm that the ack1Δ strains are not producing 
mRNA coding for Ack1p.  To demonstrate the presence of template DNA in each 
sample, amplification of an actin gene, ACT1, was performed in the same PCR reaction.  
ACT1 is expressed continuously so amplification is expected in the presence of cDNA. 
The primers designed for this experiment consisted of two separate exonic sequences 
from ACK1.  Due to the presence of introns, this allowed for differentiation between the 
amplification of cDNA versus gDNA contamination based on the size of the PCR 
product.  Amplification of cDNA was expected to yield a 1,032 bp fragment, but 
amplification of gDNA was expected to yield a 1,539 bp product.  The same principle is 
true with ACT1 PCR with the gDNA yielding a 900 bp product and the cDNA yielding an 
810 bp product.  
 PCR to verify the ack1Δ strains yielded two amplified products in the WT gDNA 
sample measure approximately 9 Kb and 1.5 Kb (Figure 1).  The larger band corresponds 
in size to the expected product length (1,539 bp) resulting from a PCR using the ACK1 
primers KIO25 and KIO26 and WT gDNA as the template.  The smaller band 
corresponds to the expected product size (900 bp) resulting from amplification of a 
portion of the actin gene ACT1 using the primers BLO1 and BLO2 and WT gDNA as the 
template.   
 The two bands in the WT cDNA samples are smaller than those seen in the WT 
gDNA sample due to the absence of introns in the cDNA.  The bands on the gel of the 
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KN99 mat α cDNA sample correspond with these expected fragment lengths (1,032 bp 
and 810 bp) demonstrating the presence of both ACK1 mRNA and ACT1 mRNA in the 
sample.   
 A single band corresponding to the size of the ACT1 fragment amplified from WT 
cDNA is noted in all the ack1Δ strains demonstrating the presence of ACT1 mRNA in the 
samples, however no amplification of ACK1 mRNA is demonstrated in any of the ack1Δ 
strains.  These findings help support the initial PCR findings that the ACK1 deletion was 
successful.  
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Figure 1:  PCR Products of cDNA Analysis to Confirm ACK1 Deletion.  
PCR products of amplification of ACK1 and ACT1 from gDNA of KN99 mat 
α (WT), cDNA from the WT, and all of the ack1Δ strains. 
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Southern Blot Analysis for ack1Δ  Strain Confirmation 
 A Southern blot was performed to allow localization of ACK1 and/or NEOR 
sequences within gDNA samples to determine which sequences are present and to ensure 
that only one deletion construct containing NEOR integrated into the ack1Δ strains.      
Autoradiography film exposure resulting from light emission from a chemiluminescent 
reaction of the alkaline phosphatase labeled ACK1 and NEOR probes following CDP Star 
application will allow for localization of the hybridized probes to complementary 
sequences within digested gDNA.       
 The ACK1 and NEOR Southern blot probes were amplified using PCR (Figure 2) 
and were checked for size by gel electrophoresis.  The ACK1 probe DNA seen located 
where we expected (519 bp) using primers KIO21 and KIO22 with WT gDNA as the 
template.  The NEOR probe DNA corresponds to the expected size of 801 bp resulting 
from amplification of ack1Δ 1.1 gDNA as the template with primers KIO23 and KIO24.  
1 Kb+ 
DNA 
ladder ACK1  Neo 
850 bp 
500 bp 
650 bp 
Figure 2:  Southern Blot Probe DNA.  1 Kb Plus DNA ladder, purified ACK1 
probe DNA (519 bp), and NEOR probe DNA (801 bp). 
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  A restriction digest was performed to cut the gDNA into smaller fragments so that 
probe hybridization would occur on a fragment of known size that could be referenced by 
a 1 Kb Plus DNA ladder.  XhoI and SpeI, were chosen for the gDNA digestion because 
these restriction sites are absent within ACK1 as well as the ack1Δ construct used to 
create the deletion strains (Figure 3).  Digestion of WT gDNA using these enzymes was 
anticipated to produce a 5,053 bp fragment that contains ACK1.  The ACK1 probe was 
expected to hybridize to a fragment of this size in the WT strain but not the in the ack1Δ 
strains since ACK1 was anticipated to be absent from the WT strain.  XhoI and SpeI 
restriction digestion of the ack1Δ strain gDNA was expected to produce a 6,073 bp 
fragment that contains NEOR.  The Southern blot using the NEOR probe was anticipated 
to hybridize to an ~6 Kb fragment only in the ack1Δ strains.  The difference in fragment 
size between the WT strain and the ack1Δ strain is due to the fact that ACK1 is 1,661 bp 
in length while NEOR is 2,681 bp in length.  The distance between the XhoI restriction 
site and the 5’ end of these two genes remains the same (1,720 bp) in both strains as does 
the distance between the 3’ end of the two genes and the SpeI site (1,672 bp).  
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The XhoI and SpeI digested gDNA (Figures 4 and 5) demonstrates two large dark bands 
of undigested WT (KN99) and ack1Δ 1.2 gDNA near the top of the gel, and smeared 
digested WT and ack1Δ gDNA.  There are no bands noted at the top of the gel horizontal 
to the undigested gDNA demonstrating full digestion of the gDNA by the endonucleases.  
The undigested gDNA samples were used as landmarks over which the dark areas of the 
samples on the autoradiography film were overlaid to allow identification of the DNA 
fragment size to which the probe hybridized using the I Kb Plus DNA ladder. 
 
 
ACK1 
XhoI SpeI 
1661 bp 1720 bp 1672 bp 
5053 bp 
5’ 3’ 
NEOR 
XhoI SpeI 
2,681 bp 1,720 bp 1,672 bp 
6,073 bp 
5’ 3’ 
!"#$%
&'()%
Figure 3:  Diagram of XhoI and SpeI Restriction Sites for Southern Blot Digest.   
Hybridization of the ACK1 probe is expected to occur on a gDNA fragment measuring 
approximately 5 Kb (top) and NEOR probe is expected to hybridize to a 6 Kb fragment 
of gDNA (bottom). 
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Undigested 
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Figure 4:  XhoI and SpeI Digested gDNA for ACK1 Southern Blot.  Image of 0.8% 
agarose gel containing 1 Kb Plus DNA ladder, undigested ACK1 and ack1Δ 1.2  
gDNA for orientation purposes.  XhoI and SpeI digested WT, and XhoI and SpeI 
digested gDNA of ack1Δ 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6.  
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 The autoradiography film from the hybridization of the ACK1 probe (Figure 6) 
demonstrates a dark band near the top of the gel in lane 2 with a less intense band at the 
same position in lane 3.  A distinct dark band is noted in the digested WT gDNA further 
down the gel, but no such band is noted in the digested ack1Δ strain samples.  Faint 
shadowing is also observed along the length of all of the lanes containing digested 
gDNA.   
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Figure 5:  XhoI and SpeI Digested gDNA for NEOR Southern Blot.  Image of 0.8% 
agarose gel containing 1 Kb Plus DNA ladder, undigested ACK1 and ack1Δ 1.2  
gDNA for orientation purposes.  XhoI and SpeI digested WT, and XhoI and SpeI 
digested gDNA of ack1Δ 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6.  
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 Overlay of the autoradiography film and the gel image of digested gDNA of the 
ACK1 probe Southern blot (Figure 7) allows size determination of the DNA fragments to 
which the ACK1 probes hybridized.  The blot overlay demonstrates that the single distinct 
band noted in the digested WT sample is located at approximately across from the 5 Kb 
ladder band.  This finding corresponds to the expected fragment size to which we 
expected the ACK1 probe to hybridize (5,053 bp).  
KN99 
 mat ! 
1 Kb + 
 DNA 
 ladder 
KN99  
mat ! 1.2 1.6 1.11 1.13 2.1 2.3 2.6 
ack1! strains ack1!  
1.2 
XhoI and SpeI digested gDNA 
Undigested 
 gDNA 
Figure 6:  ACK1 Southern Blot. Developed autoradiography film of the Southern 
blot using the ACK1 probe. 
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 The autoradiography film from the NEOR probe blot exposure (Figure 8) 
demonstrates two dark bands near the top of the gel in lanes 1 and 2.  A considerable 
amount of shadowing is noted running down each of the lanes containing digested 
gDNA.  There are, however, areas of intense banding in two locations.  There is a distinct 
intense band present higher up the blot present in the digested ack1Δ strain samples 
(lanes 5 through 11) but absent in the digested WT sample.  There is also an intense 
distinct band noted further down the gel that is present in all of the digested gDNA 
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1 Kb + 
 DNA 
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KN99  
mat ! 1.2 1.6 1.11 1.13 2.1 2.3 2.6 
ack1! strains ack1!  
1.2 
XhoI and SpeI digested gDNA 
5 Kb 
6 Kb 
Figure 7:  ACK1 Southern Blot Overlay. Overlay of the ACK1 probe film scan and 
the gel electrophoresis photograph.  	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samples.  The larger intense band that is present in the digested ack1Δ samples and not 
present in the digested WT sample is what we would expect to see with hybridization of 
the NEOR probe.  The smaller intense band that is present in all of the samples likely 
represents nonspecific binding of the probe because it is present in all of the samples.  
The smearing down the lanes also likely represents nonspecific binding of the NEOR 
probe as well.   
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Figure 8:  NEOR Southern Blot.  Developed autoradiography film of the 
Southern blot using the NEOR probe. 
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The overlay of the autoradiography film and the gel image of digested gDNA 
(Figure 9) allows for size reference of the DNA fragments to which the NEOR probes 
hybridized.  The blot overlay demonstrates that the large intense banding higher up the 
blot demonstrates hybridization of the probe to a DNA fragment measuring 
approximately 6 Kb in size.  This size corresponds to the expected size of DNA that we 
would expect the NEOR probe to bind (6,073 bp).  Notably, this intense band is not seen 
in the digested WT sample further demonstrating the absence of NEOR in the WT strain.  
The smaller distinct intense band further down the blot in all the samples of digested 
gDNA likely represents strong nonspecific binding of the probe.  
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 9:  NEOR Southern blot overlay.  Overlay of the NEOR probe film 
scan and the gel electrophoresis photograph. 
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 The results of the Southern Blot demonstrate that the DNA sequence used in the 
ACK1 probe is absent from the ack1Δ strains, and that they possess the NEOR sequence 
used for the NEOR probe.   
 Based upon the results of the cDNA analysis and Southern blot, in addition to the 
preliminary PCR that was performed when the strains were made, show that the ack1Δ 
construct strain integrated in to the correct location within the genome resulting in an 
absence of ACK1 mRNA and subsequently Ack1p in the gene deletion strains. 
Phenotype Characterization Studies 
Carbon Source Utilization: 
 With the confirmation of a clean, single integration of NEOR and removal of 
ACK1, as well as the absence of mRNA coding for ACK1 in the gene deletion strains, the 
pursuit a unique phenotype in the ack1Δ strains was commenced.  The first series of 
phenotype characterization experiments performed tested the ack1Δ strains’ ability to 
utilize different sources of carbon at different concentrations.  This was tested because 
bacteria utilize this acetate assimilation pathway as a way of handling excess Acetyl-CoA 
in high glucose environments.  The experiments testing the ack1Δ strains’ ability to 
utilize various carbon sources yielded similar growth rates and patterns between the WT 
and a variety of ack1Δ strains (Figure 10) on all of the carbon sources tested (Figures 11 - 
18).  The size of individual colonies, or lack thereof, was uniform amongst the strains.  
Additionally, growth on the 2% carbon places was noticeably better than those on the 
0.2% carbon media.  From these results it does not appear that absence of acetate kinase 
negatively or positively affects the utilization of the carbon sources tested.   
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Figure 10:  Strain Orientation for Phenotype Characterization.  
Diagram showing the strain identify on phenotype characterization plates.  
WT is denoted by star.	  
Figure 11:  Growth on YNB + Glucose.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 
0.2% glucose (left) and 2% glucose (right). 
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Figure 14:  Growth on YNB + Sorbitol.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 
0.2% sorbitol (left) and 2% sorbitol (right). 
	  
	  
Figure 13:  Growth on YNB + Sucrose.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 
0.2% sucrose (left) and 2% sucrose (right). 
Figure 12:  Growth on YNB + Galactose.  Growth of KN99 mat α and ack1Δ strains 
1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 0.2% 
galactose (left) and 2% galactose (right). 
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Figure 17:  Growth on YNB + Xylose.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 
0.2% xylose (left) and 2% xylose (right). 
Figure 16:  Growth on YNB + Glycerol.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 
0.2% glycerol (left) and 2% glycerol (right). 
Figure 15:  Growth on YNB + Ethanol.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 
0.2% ethanol (left) and 2% ethanol (right). 
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Temperature Sensitivity: 
 The ack1Δ strains were tested for temperature sensitivity as tolerance to the 
relatively warm temperature inside the human body (37˚C) is considered an important 
virulence factor.  As demonstrated in Figure 19, all of the ack1Δ strains grew equally 
well as the WT strain at room temperature (~25˚C), 30˚C, 37˚C, and 40˚C.  It is noted 
that growth is slightly less robust at RT, and the yeast begin to demonstrate growth 
inhibition at 40˚C.  Based on these results, the absence of ACK1 does not appear to 
demonstrate an alternate phenotype when subjected to the temperatures tested.   
 
 
 
 
 
Figure 18:  Growth on YNB + Sodium Acetate.  Growth of KN99 mat α and 
ack1Δ strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) 
and 0.25% sodium acetate (left), 0.5% sodium acetate (middle), and 2% sodium 
acetate (right). 
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Melanization: 
 Another important virulence factor of C. neoformans is its ability to produce 
melanin is another important virulence factor as it is believed to help protect the yeast 
from exposure to UV light and oxidative agents encountered in its environment or 
produced by phagocytic cells during an immune response to the pathogen (Casadevall 
and Perfect 1998).  The results of the melanization experiment (Figure 20) demonstrate 
brown pigmentation of the samples indicative of melanin.  The color of each colony 
appears to be the same shade of brown.  The outcome of this experiment suggests that 
Figure 19:  Temperature Tolerance on YPD.  Growth of KN99 mat α and 
ack1Δ strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 at RT (top left); 30˚C (top 
right); 37˚C (bottom left) 40˚C (bottom right).	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melanization, considered a virulence factor in C. neoformans, is not affected by the 
deletion of ACK1. 
 
 
 
 
 
 
 
 
Nitrosative Stress: 
 Another phenotype associated with C. neoformans’ pathogenicity is its ability to 
deal with the exposure to reactive nitrogen species such as nitric oxide that is experienced 
by pathogens following phagocytosis during the host immune response (Casadevall and 
Perfect 1998).  The samples streaked onto the 0.75 mM sodium nitrite (NaNO2) medium 
in Figure 21 all appear tolerate this stressor equally well.  Again, there is no obvious 
difference in phenotype upon exposure to this nitrosative stress between the WT and the 
ack1Δ strains. 
 
 
 
 
Figure 20:  Melanization.  Growth KN99 mat α and ack1Δ strains 1.2, 1.6, 1.11, 
1.13, 2.1, 2.3, and 2.6 on niger seed agar medium.	  
49	  	  
 
 
 
 
 
 
 
 
Hypoxia-Mimicking Conditions: 
 The strains’ ability to deal with hypoxic conditions is another characteristic of C. 
neoformans that enables it to cause systemic disease.  In the absence of a functioning 
hypoxic chamber, hypoxic conditions were mimicked using CoCl2.  CoCl2 mimics 
hypoxia by stabilizing a hypoxia-induced transcription factor (HIF1α) that, in the 
presence of oxygen is usually degraded (Ingavale et. al 2008).  At 0.25 mM CoCl2, the 
yeast were able to grow, however growth was significantly hindered at twice that 
concentration, and at 1 mM CoCl2 growth was almost completely inhibited in all strains 
(Figure 22).   Results of this experiment demonstrate that the phenotypic responses of all 
of the strains in response to the variable concentrations of CoCl2 were consistent 
suggesting that Ack1p does not play a significant role in the yeast’s ability to deal with a 
simulated hypoxic environment.   
 
Figure 21:  Growth Under Nitrosative Stress.  Growth of KN99 mat α and 
ack1Δ strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino 
acids) and 0.75 mM sodium nitrite.	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pH: 
 The growth studies on media with variably adjusted pH demonstrated no 
difference in growth between the ack1Δ strains and the WT strains (Figure 23).  Since C. 
neoformans is an environmental microorganism, it comes in contact with a variety of 
conditions to which it must be able to survive; however, it prefers more acidic 
environments such as bird, particularly pigeon, feces (Casadevall and Perfect 1998).  In 
this experiment, all the strains grew similarly on each of the plates, with growth being 
slightly inhibited on the pH 11 medium.  As a result, no difference in phenotype was 
identified in this experiment. 
Figure 22:  Growth Under Simulated Hypoxia.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 0.25 
mM CoCl2 (left), 0.53 mM CoCl2 (center), and 0.7 mM CoCl2 (right).  
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Filamentation During Sexual Reproduction:  
 While C. neoformans primarily reproduces asexually via budding, interaction 
between the two mating types, mat a and mat α, result in the production of filaments and 
basidiospores.  While cryptococcosis most commonly manifests itself in the lungs, it is 
not definitively known if inhalation of basidiospores or desiccated yeast cells are the 
culprit (Casadevall and Perfect 1998).  The ability of the ack1Δ strains to produce 
filaments indicative of sexual reproduction demonstrated no phenotypic difference 
Figure 23:  Effect of pH on Growth.  Growth of KN99 mat α and ack1Δ strains 1.2, 
1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YPD (without amino acids) at pH 5 (top left), pH 7 
(top right), pH 9 (bottom left), pH 11 (bottom right). 
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(Figure 24).  Filamentation observed in the WT strain as well as the ack1Δ strains were 
present in similar abundance.  Interestingly, upon completion of this experiment it was 
noted that the ack1Δ strains, originally believed to be of the mating type-α, were instead 
of the mat-a mating type.  This was discovered because the ack1Δ strains only mated and 
produced filaments with the WT mat-α strain.  This was discussed and is believed that 
the phenotypes explored in this study would not be affected by mating type.   
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KN99 mat α X KN99 mat a     KN99 mat α X ack1Δ 1.2    KN99 mat α X ack1Δ 1.6 
   KN99 mat α X ack1Δ 1.13 	  	  	  KN99 mat α X ack1Δ 2.1    KN99 mat α X ack1Δ 1.11 
   KN99 mat α X ack1Δ 2.3    KN99 mat α X ack1Δ 2.6 
Figure 24:  Filamentation During Sexual Reproduction.  Hyphal filamentation 
from mating of KN99 mat α and ack1Δ strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on 
Murashige-Skoog medium. 
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Oxidative Stress: 
 The response to oxidative stress experienced upon exposure to varying 
concentrations of H2O2 was tested using ack1Δ strains and the WT strain.  Similar to 
nitrosative stress, pathogenic microorganisms are exposed to reactive oxygen species by 
the phagocytic cells of the host’s immune system (Casadevall and Perfect 1998).  All of 
the strains except ack1Δ 1.13 grew on the medium containing 0.25 mM H2O2 and growth 
was absent from all strains at 0.5 mM and 1 mM H2O2 (Figure 25).  Although ack1Δ 1.13 
did show different phenotypes than the WT, it appears unlikely that the difference can be 
attributed to the ACK1 deletion since no other ack1Δ strain exhibits this unique 
phenotype.  It is likely that this phenotype is the result of a second gene mutation, and 
resolving this interesting result would make an interesting classic forward genetic study.  
As for the other ack1Δ strains, it appears that no phenotypic difference was found in the 
strains’ ability to deal with the oxidative environment to which they were subjected. 
 
Figure 25:  Oxidative Stress Phenotypes.  Growth of KN99 mat α and ack1Δ strains 
1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids) and 0.25 mM 
H2O2 (left), 0.5 mM H2O2 (center) and 1 mM H2O2 (right).   
	  
* * * 
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Cluster Growth Phenotype: 
 Several attempts at performing a growth curve on the cells were made however 
clustering or “clumping” of the cells inhibited accurate cell counts.  Initially, it was 
thought that only the ack1Δ strains were exhibiting this phenotype so attention was 
directed to definitively determining if this phenomenon was unique to the mutant strains.  
Observations of the WT and several of the deletion strains grown in YPD (50 g/L)  and in 
minimal media demonstrated that none of the strains grown in YPD (50 g/L) exhibited 
the clustering phenotype, and all of the strains grown in minimal media demonstrated this 
effect (Figures 26 and 27).  It is believed that the yeasts’ reaction to the minimal medium 
is resulting in this phenomenon rather than the result of the gene deletion. 
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Figure 26:  Clustering Phenotype in YPD.  Growth of KN99 mat α (top left); 
ack1Δ 1.2 (top right); ack1Δ 1.11 (middle left); ack1Δ 1.13 (middle right); ack1Δ 
2.3 (bottom) in YPD at 30˚C. 
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Figure 27:  Clustering Phenotype in Minimal Medium.  Growth of KN99 mat α 
(top left); ack1Δ 1.2 (top right); ack1Δ 1.11 (middle left); ack1Δ 1.13 (middle right); 
ack1Δ 2.3 (bottom) in YPD at 30˚C.	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Polysaccharide Capsule Formation: 
Perhaps one of the most important virulence factors and one of the most striking 
characteristics C. neoformans possesses is the ability to synthesize a polysaccharide 
capsule.  It is believed that this capsule serves numerous functions including offering 
protection from environmental conditions and hindering phagocytosis (Casadevall and 
Perfect 1998).  According to the observations made following incubation in the capsule-
inducing medium, there is a pronounced white halo surrounding the WT and the ack1Δ 
strain cells following staining with India ink, demonstrating their ability to synthesis a 
capsule (Figure 28).  Notably, however, ack1Δ 1.13 appears to make a more robust 
capsule than is seen in all of the other strains tested.  With the exception of ack1Δ 1.13, 
the capsules visually appear similar to those demonstrated by the WT.  The capsules vary 
considerably in size within each sample, and the cells appear to be more clustered, similar 
to those encountered in the cluster growth phenotype experiment.  This is possibly due to 
the nutrient poor medium in which these cells were grown.  According to these results, it 
does not appear that ACK1 visibly affect the synthesis of the polysaccharide capsule.   
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Cell Wall Integrity: 
In addition to secreting a polysaccharide capsule, C. neoformans possesses a cell 
wall that provides structure and protection for the cell.  The cell wall integrity of the 
ack1Δ strains was tested with SDS and Congo Red stain (Figure 29).  The mutant strains 
Figure 28:  Polysaccharide Capsule Formation.  Capsule formation of KN99 mat α 
(top left – previous page), ack1Δ 1.4 (top right - previous page), ack1Δ 1.6 (middle 
left), and ack1Δ 2.4 (bottom) in capsule inducing medium. 
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tolerated the amphiphilic property of the SDS.  Likewise, the WT and ack1Δ strains 
demonstrated no phenotypic difference when exposed to Congo red stain.  
 
 
 
 
 
 
 
 
 
 
ACK1 Complementation Construct for Electroporation 
 Construction of a plasmid that could be utilized to expression ACK1 in the gene 
deletion strains following discovery on a unique phenotype was successful.  The hope is 
that any deviation of phenotype expressed by the ack1Δ strains would be reverted back to 
the WT phenotype upon expression of ACK1 via this plasmid-based complementation 
construct.  
 The first part of this project involved PCR amplification of ACK1 using primers 
with sequences approximately 1 Kb upstream and approximately 250 bp downstream of 
ACK1.  SpeI restriction sites were added to the 5’ end of the sense primer (BLO11) and to 
the 3’ end of the antisense primer (BLO12).  These SpeI sites were used for insert and 
vector ligation.  The ACK1 insert and the pHYG7-KB1 vector were both digested with 
Figure 29:  Cell Wall Integrity.  Growth of KN99 mat α and ack1Δ 
strains 1.2, 1.6, 1.11, 1.13, 2.1, 2.3, and 2.6 on YNB (without amino acids)  
+ 0.01% SDS (left) and on YNB + 0.5% Congo Red (right). 
* * 
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SpeI in preparation for the ligation reaction.  The gel image of the digested and purified 
pHYG7-KB1 vector in lane 2 (Figure 30) demonstrates a single clean band located near 
the 5 Kb and 6 Kb bands of the DNA ladder.  This corresponds to the expected length of 
the vector of 5,661 bp.  The gel of the digested and purified ACK1 insert demonstrates a 
single clean band located slightly above the 3 Kb band of the ladder, corresponding to the 
expected length of 3,041 bp.  The bands of the vector and insert appear to be similar of 
intensity indicating a similarity in DNA concentration.  Visualization of ligation 
components aids in the determination of volume used in the ligation reactions.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6 Kb 
3 Kb 
1 Kb+  
 DNA 
ladder 
pHYG7-KB1 
(vector) 
ACK1 
(insert) 
Figure 30:  ACK1 Complementation Construct Components.  SpeI digested 
pHYG7-KB1 vector and ACK1 insert used for constructing the ACK1 
complementation plasmid. 
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 Bacterial transformation of the ligation reaction on LB + Amp plates yielded 48 
colonies.  Twenty-six colonies were present on the linearized vector plate and no colonies 
were noted on the control plate.  The absence of colonies on the control plate indicates 
that the selectable marker ampicillin is working.  The only colonies that arise on this 
medium should have taken in the plasmid that confers resistance to ampicillin.  As noted 
in the results of the transformation, fewer E. coli cells are successfully transformed with 
linearized vectors.   
 Colony PCR was used to quickly identify transformants containing the ACK1 
complementation construct.  Primers KIO21 and KIO22, consisting of ACK1 sequences, 
were used to amplify a 516 bp segment of this gene.  The gel image of the colony PCRs  
(Figure 31) performed on the first eight colonies from the transformation plate 
demonstrates bright, clean, single bands located just above the 500 bp band of the DNA 
ladder from colonies #2 and #7.  This corresponds to the expected size of the PCR 
product.  None of the other colonies demonstrated amplification. 
 
 
 
 
 
 
 
 
 
63	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
A XbaI restriction digest was performed to determine the orientation of the ACK1 
insert into the vector.  This endonuclease was chosen because there are two XbaI 
restriction sites present in the construct, one located near one ligation site and the other 
present near one end of the construct.  The XbaI restriction sites are situated close to one 
another with an antisense orientation of the insert.  A XbaI restriction digest on an 
antisense oriented insert is expected to produce two fragments measuring 315 bp and 
8,383 bp.  However, because one fragment is so small, in order to allow adequate 
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Figure 31:  Colony PCRs from the ACK1 Complementation Ligation.  Colony 
PCRs of colonies #1 - #8 following transformation of E. coli with the ACK1 
complementation plasmid.  
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separation of the larger fragments the gel could possibly demonstrate only a single band 
measuring approximately 8 Kb.  Ligation of the ACK1 insert in the sense orientation 
would situate the two XbaI restriction sites further apart.  Following a XbaI restriction 
digest of a construct of this type, two fragments, one measuring 2,730 bp and the other 
measuring 5,968 bp would be anticipated.     
 The gel of the XbaI digests of gDNA from colonies #2 and #7 (Figure 32) 
demonstrates two different results from the two colonies.  The digest of colony #2 gDNA 
demonstrates two bands, one located just below the 3Kb band of the ladder and the other 
located at approximately the 6 Kb band of the ladder.  These products correspond to a 
sense orientation of the ACK1 insert in the ACK1 complementation construct.  The digest 
of colony #7 gDNA demonstrates a single large band located at approximately between 
the 8 and 9 Kb bands of the ladder.  This result corresponds to an antisense orientation of 
the ACK1 insert in the ACK1 complementation construct.  So, by chance, both insert 
orientations were obtained from the two colonies tested.    
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ACK1-mCherry Strain Development 
 The purpose of creating these ACK1-mCherry strains was to hopefully enable 
visualization of where AK is utilized within the cell.  This is performed by inserting the 
sequence that codes for a small red fluorescent protein direction adjacent to the end of 
AK, removing the ACK1 stop codon in the process.  Not only with this allow for 
subcellular localization of AK, but it will also allow AK to be purified from cell lysate 
using anti-mCherry beads.  Protein isolated from the cell could then be used for enzyme 
kinetic studies. 
1Kb+ 
 DNA 
 ladder 
Uncut  
pHYG7KB1 
(- control) 
Digested  
pHYG7KB1 
Colony #2  
pBB1.1 
Colony #7  
 pBB1.2 
3 Kb 
4 Kb 
5 Kb 
6 Kb 
7 Kb 
Figure 32:  XbaI Digest for ACK1 Insert Orientation.  Gel electrophoresis of the 
uncut vector (pHYG7-KB1) and XbaI digested pHYG7-KB1, colony #2, and colony 
#7 for ACK1 insert orientation determination within the ACK1 complementation 
plasmid. 
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 The initial approach to developing the ACK1-mCherry strain was to produce the 
construct using overlap PCR in which three fragments that comprise the construct each 
contain small overlapping sequences on the 5’ and 3’ ends of the adjacent fragments.  
Following many unsuccessful attempts, an alternative method was utilized.  This 
approach involved the introduction of specific restriction sites or utilization of existing 
restriction sites at the 5’ and 3’ ends of adjacent components of the construct as well as 
the vector (pCR2.1 Topo) into which the construct is cloned.  As demonstrated in Figure 
33, a BamHI site was introduced into the sense primer (KIO27) for the PCR of the first 
fragment that contains the ACK1 promoter and ACK1.  A single BamHI site present in the 
vector was used to ligate the 5’ end of the construct to the vector.  Additionally, there is 
not a BamHI site present in fragment 1 which allows digestion of the 5’ end BamHI site 
without cutting another site within the fragment.  The antisense primer (KIO28) was 
designed to remove the ACK1 stop codon and introduce a SpeI site on the 3’ end.  Like 
the BamHI site, there is no other SpeI site in fragment 1 which allowed digestion of the 3’ 
end SpeI site without disrupting the rest of the fragment.  
 The second fragment, consisting of mCherry and NEOR, was prepared using 
primers KIO29 and KIO30 that introduced a SpeI site on the 5’ end and a NdeI site on the 
3’ end.  The SpeI site was specifically chosen to link fragments 1 and 2 due to the fact 
that it is a 6 base pair restriction site.  This would allow the linking of ACK1 with 
mCherry without causing a shift in the codon reading frame.  
 The third fragment consisting of the 3’ untranslated region of ACK1 was prepared 
using a sense primer (KIO31) that introduced an NdeI site on the 5’ end to which the 3’ 
end of the second fragment ligated.  The antisense primer of fragment 3 (KIO32) 
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introduced a KpnI site to the 3’ end of the fragment.  This end was ligated to the single 
KpnI site present in the vector.  
 
 
 
  
 
 
Following amplification of the three fragments comprising the ACK1-mCherry 
construct, restriction digests using the appropriate endonucleases were performed on 
these fragments as well as the vector, pCR2.1 TOPO.  These restriction digests were PCR 
purified and visualized via gel electrophoresis.  As demonstrated in Figure 34, the sizes 
of each fragment and the vector correspond to the expected sizes of 2,748 bp for fragment 
#1, 3,200 bp for fragment #2, 1,012 bp for fragment #3, and 3,908 bp for the vector.  
Additionally, the gel was used to determine the relative concentrations of each 
component of the construct to help determine component volumes used in the ligation 
reactions.  Fragments 1 and 3 appear very similar in concentration, fragment 2 appears to 
be of lowest concentration, and the vector appears to be the most concentrated of all the 
components.
Figure 33:  ACK1-mCherry Construct.  Diagram of the ACK1-mCherry construct 
demonstrating the primers used to amplify each fragment and the restriction sites 
used to ligate the construct together. 
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 Following ligation and transformation of the ligation reaction into DH5α 
competent E. coli cells, colony PCRs using primers KIO21 and KIO22 were performed to 
rapidly determine the presence of ACK1 within the transformants.  Figure 35 
demonstrates the gel image of a series of colony PCRs that were performed on the 
transformation colonies.  A faint band is noted in numerous samples located just above 
!
Figure 34:  Digested and Purified ACK1-mCherry Construct Fragments.  Gel 
electrophoresis of BamHI and SpeI digested and purified fragment #1, SpeI and 
NdeI digested and purified fragment #2, NdeI and KpnI digested and purified 
fragment #3, and BamHI and Kpn digested and purified vector.	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the 500 bp band of the marker.  Colony #A8 demonstrates a single bright band at the 
same location.  This fragment size corresponds to the expected fragment size of 516 bp 
resulting from the primers utilized and the presence of ACK1. 
 
 
 
 
 
 
 
 
  
 
 To confirm the presence of the entire ACK1-mCherry construct, minipreps were 
performed on colony #A8, the colony that demonstrated the bright single band following 
colony PCR, as well as colonies #B6, #B7, #B10, and #B11, colonies that demonstrated a 
faint band at the expected location, and a XhoI restriction digest was performed on the 
plasmid DNA.  The gel image of the products of the XhoI digest (Figure 36) demonstrates 
undigested A8 plasmid DNA (negative control) in lane 2, and two distinct bands are 
noted in the colony A8 sample, the larger of which is located around the 7 Kb band of the 
ladder and the smaller fragment located just above the 4 Kb marker of the ladder.  A 
!
Figure 35:  Colony PCR of ACK1-mCherry Transformants.  Colony PCR 
products from colonies A1-A8 and B6-B11 following transformation of competent 
E. coli using the ligation reaction of the ACK1-mCherry construct. 
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single bright band located at around the 4 Kb marker is noted in the digest of colonies B6, 
B7, and B10, and a single bright band located between the 5 Kb and 6 Kb markers of the 
DNA ladder.  The plasmid DNA from colony A8 is the only sample that demonstrates the 
expected fragment sizes of 4,011 bp and 6,774 bp resulting from a XhoI digest of the 
complete ACK1-mCherry construct plasmid (Figure 37). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 36:  XhoI Restriction Digest of ACK1-mCherry Construct.  XhoI 
restriction digest on minipreps from colonies A8, B6, B7, B10, and B11 for 
confirmation of complete ACK1-mCherry construct.	  
Uncut 
A8 
Control A8 B6 B7 B10 B11 
1 Kb+ 
DNA 
ladder 
4 Kb 
5 Kb 
6 Kb 
7 Kb 
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 Following XhoI digest confirmation of the plasmid, the entire ACK1-mCherry 
construct was PCR amplified and purified in preparation for biolistic transformation of 
KN99 mat α cells.  The sense primer of the first fragment (KIO27) and the antisense 
primer of the third fragment (KIO32) were used to amplify the entire construct.  Figure 
38 demonstrates the products of four ACK1-mCherry construct PCRs each consisting of a 
single band of varying concentrations each located at around the 7 Kb band of the DNA 
ladder.  This fragment size corresponds to the expected size of 6,900 bp.  Each reaction 
contains the same components and only varies by annealing temperature.  Good 
amplification is demonstrated with the annealing temperatures of 63˚C (sample #2), 
63.5˚C (sample #3), and 64˚C (sample #4). 
Figure 37:  XhoI Restriction Sites Within the ACK1-mCherry Plasmid.  
Diagram demonstrating expected fragments expected from a XhoI restriction 
digest of the ACK1-mCherry plasmid.	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 Following biolistic transformation, two PCRs, each confirming one end of the 
construct, were performed as an initial screening to assess successful homologous 
recombination with the ACK1-mCherry construct.  Confirmation of the 5’ end of the 
construct was performed using primers KIO33 and BLO45.  The sequence of primer 
KIO33 is located upstream of the 5’ end of the construct, and the sequence of antisense 
primer BLO45 is located within mCherry.  Primers BLO46 and KIO12 were used to 
confirm placement of the 3’ end of the construct.  The sequence of primer BLO46 is 
!"#$
%&'$
()**+,$ -!$ -.$ -/$ -0$
1$"#$
Figure 38:  PCR of ACK1-mCherry Construct. The gel demonstrates 
amplification of the 6,900 bp ACK1-mCherry insert used for biolistic 
transformation. 
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found within NEOR and that of primer KIO12 is found downstream of the ACK1-
mCherry construct.  Each PCR contains a primer within the construct and the other 
primer outside of the construct.  Therefore, amplification of the 5’ and 3’ ends using 
gDNA from the biolistics transformants and the above mentioned primers demonstrates 
that at least one copy of the ACK1-mCherry construct integrated successfully into the 
correct location within the genome.   
 Placement PCRs performed on one gDNA sample from each biolistics plate is 
demonstrated in Figures 43 and 44.   The gel image of the 5’ end confirmation PCRs 
(Figure 39) demonstrates well-amplified fragments located between the 3 Kb and 4 Kb 
bands of the DNA ladder corresponding to the expected fragment length of 3,181 bp in 
each of the transformant gDNA samples, with the exception of colony 63.  In addition, 
this band is not present in the WT gDNA sample as expected since the antisense primer 
for this reaction consists of a sequence of mCherry.  A variety of faint bands are seen in 
each of the samples, likely representing nonspecific binding of primers at similar 
sequences.   
 
 
 
 
 
 
 
 
74	  	  
 
 
   
 
 
 
 
  
 
 
  
 
The gel image of the 3’ end confirmation PCRs (Figure 40) demonstrate well-
amplified fragments located between the 2 Kb and 3 Kb ladder bands from colonies #6, 
#23, #46, #83, and #104.  This corresponds to the expected length of 2,146 bp.  No band 
is noted in the WT or colony #63 gDNA samples.  As with the 5’ end confirmation, this 
band is not demonstrated in the WT gDNA sample since the sense primer BLO46 
consists of a NEOR sequence that is not present within the WT genome.  The absence of 
amplification of gDNA from colony #63 indicates that that particular transformant does 
not possess the entire ACK1-mCherry construct.   No other bands are noted in the gel. 
!
Figure 39:  PCRs of ACK1-mCherry 5' End Placement Confirmation.  PCR 
products of 5’ untranslated region, ACK1, and NEOR of the ACK1-mCherry construct 
using gDNA from biolistics colonies 6, 23, 46, 63, 83, and 104 for confirmation of 5’ 
end integration within the genome. 
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Figure 40:  PCRs of ACK1-mCherry 3' End Placement Confirmation.  PCR 
products of the NEOR and 3’ untranslated region of the ACK1-mCherry construct 
using gDNA from biolistics colonies 6, 23, 46, 63, 83, and 104 for confirmation of 3’ 
end integration within the genome. 
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CONCLUSION 
 
 
 
 The goal of the research presented here was to confirm ACK1 gene deletion 
strains that were created by Dr. Bose for use in this work and try to elucidate a phenotype 
that deviates from the wild type.  A construct was produced for use as a complementation 
in the event that a unique phenotype was observed, a strain in which ACK1 is tagged with 
the gene that codes for a red fluorescent protein, mCherry, was created in hopes of 
discovering where the protein is localized within the cell and to enable purification of the 
protein for enzyme assays.   
 cDNA analysis demonstrated the absence of mRNA coding for ACK1, and the 
Southern blot analysis confirmed a single successful homologous recombination, 
replacing ACK1 with the NEOR deletion cassette.  Unfortunately, the phenotype 
characterization studies attempted in this work failed to demonstrate an alternate 
phenotype different from that exhibited by the wild-type strain (KN99).  In the absence of 
a variant phenotype, the construct created in this work for extra-chromosomal ACK1 
expression for complementation studies was prepared but not utilized.   
 The lack of phenotypic difference between the WT and the ack1Δ strains is 
perplexing, however, due to the relatively new discovery of potential ackA homologs in 
eukaryotic microbes, little has been established as to their role within organisms of this 
domain.   
 It is quite possible that this homolog does not have analogous function in 
eukaryotes.  Entamoeba histolytica, a eukaryotic organism in which a homolog for 
acetate kinase was found, did not demonstrate a homolog for PTA or XFP, the two 
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enzymes that produce the substrate utilized by AK (Ingram-Smith et al. 2006).  It was 
hypothesized that, in light of those findings, AK in E. histolytic could play a novel role. 
(Ingram-Smith et al. 2006).  While it was found that a homolog for PTA was not 
identified, two homologs for XFP were found, XFP1p and XFP2p.  One method that 
could be used to determine if the homologs of XFP work together with AK in the acetate 
assimilation pathway is to construct separate mutant strains in which each XFP1 and 
XFP2 is deleted as well as two strains that include double deletes of each of the XFPs and 
ACK1.  These strains could be utilized for phenotype characterization studies along with 
the ack1Δ strains that were created for this study.  Studies similar to this involving other 
proteins involved in the acetate assimilation pathway, such as ACS, could also be 
approached to gain a better understanding of how or if these enzymes work together. 
 Another potential approach to elucidating AK function would be to study the 
gene’s expression pattern under various conditions.  Clues as to protein function can 
often be obtained by discovering factors that influence gene expression [Alberts et al. 
2002].  If acetate kinase plays a subtler role, detecting changes in expression could help 
narrow down the field of potential phenotype characterization experiments by honing in 
on stimuli that affect gene expression. 
 The ACK1-mCherry strain that was produced might reveal information about 
where in the cell this protein is utilized.  PCR amplification of the 5’ and 3’ ends of 
ACK1-mCherry strains suggest correct placement of the construct within the genome.   
In-house fluorescence and confocal microscopy utilized for subcellular localization of the 
mCherry-tagged Ack1p was attempted, however, no visualization of the red fluorescent 
protein-tagged enzyme was observed.  It is not known if the absence of red fluorescence 
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is due to the lack of AK production in the cells or due to hardware issues such as the 
necessity of a camera on the microscope or an update in the software for the confocal 
microscope.  It was noted, however, that positive control strains for green fluorescence 
protein (GFP) also failed to demonstrate fluorescence.  A western blot of cell lysate using 
antibodies against the mCherry protein could indicate the presence of the tagged protein.  
The mCherry tags can also be used to pull down the protein for use in enzyme assays.  
Protein studies of endogenous acetate kinase from C. neoformans could also help reveal 
its function.  Learning more about the enzyme kinetics of the protein itself might provide 
clues as to its biological role.   
 The discovery of homologous proteins, previously thought limited to prokaryotes, 
in eukaryotic organisms has opened a new arena in which little is known.  The interest in 
this particular enzyme stems from the fact that several of the eukaryotic microbes 
possessing this protein can be pathogenic as is the case with C.  neoformans.  The 
apparent absence of AK homologs in higher eukaryotic organisms motivates the desire to 
understand its role since proteins and metabolic pathways that are unique to pathogens 
can be potential targets by therapeutic agents.  It is hopeful that continued research will 
help elucidate the function of acetate kinase in C. neoformans. 
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APPENDIX A 
 
 
 
List of primers 
 
Primer 
Number 
Primer Sequence (5’ to 3’) Gene 
BLO01 CTTGGTCATTGACAATGGCTC ACT1 
BLO02 GTCTCGTGGATACCAGCAGC ACT1 
BLO11 GACTAGTGCCATACAGACGAATGACTG ACK1 
BLO12 GACTAGTCCGTCGATATATGAGAAGCC ACK1 
BLO45 CACCCTTGGTCACCTTCAGC ACK1 
BLO46 GGATCTCGTCGTGACCCATG NEOR 
KIO12 CATGCTCTGATTGGCTTCTCAC ACK1 
KIO21 CGTAAGTAGAGTCGAAACTCG ACK1 
KIO22 GCTTTAGAGACGGTGAAGTC ACK1 
KIO23 CTGCATCCATCTGCCTTGTC NEOR 
KIO24 CATGATATTCGGCAAGCAGG NEOR 
KIO25 CTCGCTGTGACCAATATCAGC ACK1 
KIO26 GCTAGCTTCTTCAGCACATCC ACK 
KIO27 CGGGATCCAGAGTGTTGTGCACGTCAC  ACK1 
KIO28 GACTAGTAAACCCAAATTCCTCCTTG ACK1 
KIO29 GACTAGTCATGGTGAGCAAGGGCGAG mCherry 
KIO30 GGAATTCCATATGTGGTTTATCTGTATTAACACGG NEOR 
KIO31 GGAATTCCATATGGCGAACTTAGTGGGTCTTGAC ACK1 
KIO32 CGGGGTACCATCAATAAAAGCTTTCTTCACTCC ACK1 
KIO33 GCAAACACCAAGAATGTCTCG ACK1 
